Understanding colorectal cancer in Hispanic patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a detailed cohort of Hispanic patients diagnosed with colorectal cancer, collecting genetic, clinical, and outcome data. By analyzing blood and tumor tissue samples, the study seeks to identify genomic predictors of treatment outcomes and explore the gut microbiome's role in cancer progression. Additionally, it will assess patient engagement in genetic testing and the impact of comorbidities on treatment responses. The ultimate goal is to enhance personalized medicine approaches for this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Self-reported Hispanic ethnicity
* Diagnosed with colon or rectal cancer (at any time and stage; lifetime diagnosis and in survival are eligible)
* Has a tumor tissue sample archived or plans to have tissue archived from a standard care procedure
* Age \>= 18 years
* Ability to understand and the willingness to sign a written informed consent.
* For those who would like to participate in the optional microbiome characterization aspect of the study, the patient will have to be under 40 years old at any clinical cancer stage or over 60 years old at any clinical cancer stage.

Exclusion Criteria:

* Inability to understand and the willingness to sign a written informed consent

Where it's running

• Los Angeles County-USC Medical Center
  Los Angeles, California, United States Recruiting
• USC / Norris Comprehensive Cancer Center
  Los Angeles, California, United States Recruiting

Study contacts

• Principal investigator: Heinz-Josef Lenz, MD — University of Southern California
• Study coordinator: Ashley Noriega
• Email: Ashley.Noriega@med.usc.edu
• Phone: 323-865-3000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exercise after pelvic radiation to see if it lowers colorectal cancer risk

  This study tests whether regular walking therapy after pelvic radiation for prostate cancer can influence markers of colorectal cancer in colon tissue and blood.

  Recruiting at 2 sites City of Hope Medical Center · Duarte, California and 1 other locations · NCT07790718

• Irreversible Electroporation for Recurrent Pelvic Tumors

  This study tests whether using irreversible electroporation (IRE) is safe and helps control recurrent pelvic tumors in adults who can’t have other local treatments.

  Recruiting Amsterdam UMC, location VUmc · Amsterdam, North Holland · NCT07782164

• Smart Symptom Tracking with ALEX for GI Health in Young Adults

  This trial tests whether the Smart Symptom Tracking ALEX app can better track GI symptoms in young adults (18–44) compared with standard paper logs.

  Recruiting Mayo Clinic · Jacksonville, Florida · NCT07618273

• Culturally adapted online genetic counseling and testing education for African American cancer survivors

  We will test a culturally adapted online genetic counseling program to see if it increases genetic counseling and genetic testing among African American breast, prostate, and colorectal cancer survivors.

  Recruiting Barbara Ann Karmanos Cancer Institute · Detroit, Michigan · NCT07436078

• Zanidatamab given before surgery for HER2-positive colon or rectal cancer

  This tests whether giving zanidatamab before surgery helps adults with HER2-positive, RAS‑wildtype colon or rectal cancer who are planned for curative treatment.

  Recruiting at 4 sites Phase 2 Emory University · Atlanta, Georgia and 3 other locations · NCT07405476

• In-home cancer treatment with remote specialist support for patients in the Florida Panhandle

  This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07285044

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.